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Adipose tissue functions as an endocrine organ, and the development of systemic inflammation in adipose
tissue is closely associated with metabolic diseases, such as obesity and insulin resistance. Accordingly, the
fine regulation of the inflammatory response caused by obesity has therapeutic potential for the treatment of
metabolic syndrome. In this study, we analyzed the role of DJ-1 (PARK7) in adipogenesis and inflammation
related to obesity in vitro and in vivo. Many intracellular functions of DJ-1, including oxidative stress
regulation, are known. However, the possibility of DJ-1 involvement in metabolic disease is largely
unknown. Our results suggest that DJ-1 deficiency results in reduced adipogenesis and the down-regulation
of pro-inflammatory cytokines in vitro. Furthermore, DJ-1-deficient mice show a low-level inflammatory
response in the high-fat diet-induced obesitymodel. These results indicate previously unknown functions of
DJ-1 in metabolism and therefore suggest that precise regulation of DJ-1 in adipose tissue might have a
therapeutic advantage for metabolic disease treatment.
A
dipose tissue is a complex organ that is required for energy homeostasis. This tissue is primarily composed
of adipocytes and contains diverse cellular types, including fibroblasts, fibroblastic pre-adipocytes,
endothelial cells and immune cells1. Adipocytes contain a single large lipid droplet surrounded by a thin
rim of cytoplasm that lies between the droplet and the plasmamembrane2. Adipocytes within white adipose tissue
(WAT) store excess energy in the form of triglyceride and release free fatty acids in response to energy require-
ments such as fasting3. Additionally, adipocytes secrete hormones and cytokines (adipokines) that affect whole-
body energymetabolism functions such as glucose metabolism, appetite and inflammation. Accordingly, adipose
tissue functions as an endocrine organ as well as an energy storage organ4,5. The dysfunction of the adipose tissue
is associated with the pathological consequences of metabolic diseases, most notably obesity, insulin resistance
and type 2 diabetes.
Many studies have suggested that chronic inflammation is a key feature of obesity-related insulin resistance6–8.
Obesity alters the cellular composition in WAT. Macrophage infiltration of adipose tissue is observed in obese
conditions in both humans and mice, and this recruitment is linked to systemic inflammation and insulin
resistance. Many pro-inflammatory cytokines, including tumor necrosis factor-a (TNF-a) and interleukin-6
(IL-6), are elevated in WAT with obesity and these cytokines have direct effects on cellular metabolism.
Additionally, many reports have shown that oxidative stress is increased in WAT as obesity develops9,10.
Increased oxidative stress in WAT affects other metabolic organ, including liver and skeletal muscle as well as
WAT itself, via the dysregulation of adipokines and leads to insulin resistance and diabetes. These reports
proposed that increased oxidative stress is one cause of obesity-associated metabolic syndrome and that factors
regulating oxidative stress might be useful target for new therapies.
DJ-1 (PARK7) is a 189-amino-acid protein that is ubiquitously expressed in mammalian tissues11. A loss of
functionmutation ofDJ-1 causes early onset familial Parkinson’s disease12.Many reports have proposed that DJ-1
functions as a survival factor and an antioxidant protein and that Cys106 is necessary for antioxidant capacity of
DJ-113. DJ-1 prevents cell death from oxidative stress, and DJ-1 deficiency increases susceptibility to oxidative
stress14–16. The antioxidant function of DJ-1 is also observed in tissues other than the brain. Indeed, DJ-1-deficient
mice show a reduced b-cell area of pancreatic islets and reduced insulin secretion in response to aging and an
high-fat diet (HFD) and it is suggested that DJ-1 deficiency results in the dysregulation of oxidative stress and the
dysfunction of pancreatic islets17. However, so far there have been few studies of the effects of DJ-1 on adipogen-
esis and metabolic regulation.
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In the present study, we have investigated the role of DJ-1 in
adipogenesis and inflammation associated with obesity-associated
metabolism. We observed that DJ-1 deficiency results in reduced
adipogenesis and inflammatory cytokine expression in 3T3-L1 cells.
Furthermore, to further understand the role of DJ-1 in vivo, we
applied the HFD model for 12 weeks and detected reduced inflam-
mation in DJ-1-deficient mice. These results indicate previously
unknown functions of DJ-1 in adipogenesis and metabolism and
suggest that selective regulation of DJ-1 is a promising new thera-
peutic target for treating obesity-related metabolic diseases.
Results
Expression of DJ-1 is up-regulated during adipogenesis in 3T3-L1
cells. To examine the putative role of DJ-1 in adipogenesis, we ana-
lyzed DJ-1 expression in 3T3-L1 cells caused by adipogenic differen-
tiation. The 3T3-L1 cell line is a mouse pre-adipocyte line that is
widely used as a cellular model of adipogenesis18. To confirm adipo-
genic differentiation, the expression of adipogenic markers was also
examined. During adipogenesis in 3T3-L1 cells, the mRNA level of
DJ-1 is increased (1.6–4.6 folds) and, simultaneously, the expression
of adipogenic markers1,18,19, such as peroxisome-proliferator-activated
receptor-c (PPAR-c) (2.2–57.3 folds), CCAAT/enhancer-binding
protein-a (c/EBP-a) (8.0–65.5 folds) and adipocyte protein 2 (aP2)
(184.2–3019.5 folds), was up-regulated during adipogenic differentia-
tion (Fig. 1a). Additionally, we confirmed that the protein level of DJ-
1 was up-regulated under adipogenic differentiation conditions
(Fig. 1b). The protein level of DJ-1 was increased during adipo-
genesis in 3T3-L1 cells, and adipogenic marker expression was also
examined. However, the secretion of DJ-1 was not altered during
adipogenesis in 3T3-L1 cells (data not shown). These results show
Figure 1 | Expression of DJ-1 is increased during adipogenesis. (a) The gene expression level changes of DJ-1 and adipogenic markers, including PPAR-
c, C/EBP-a and aP2 caused by the adipogenic differentiation of 3T3-L1 cells. The mRNA level was determined by quantitative RT-PCR. *, p , 0.05
and **, p, 0.01 versus day 0. (b) The protein levels of DJ-1 and adipogenic markers were examined by immunoblotting during adipogenesis in 3T3-L1
cells. The expression of HSC70 was used as a normalized control. All data are presented as the mean 6 s.d.
www.nature.com/scientificreports
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that the expression of DJ-1 mRNA and the levels of DJ-1 protein are
up-regulated in response to adipogenic conditions from the early
stages of differentiation.
Endogenous DJ-1 contributes to adipogenesis in 3T3-L1 cells.
Because DJ-1 expression was enhanced during adipogenesis in
3T3-L1 cells, we investigated the role of endogenous DJ-1 in
adipogenic differentiation by transfecting siRNA targeting DJ-1.
The knock-down of DJ-1 by siRNA treatment was confirmed by
immunoblotting (Fig. 2a). Cell viability was not affected by DJ-1
deficiency at 0 d or 6 d after adipogenesis induction (Fig. 2b).
However, surprisingly, DJ-1 deficiency resulted in reduced
adipogenic differentiation and lipid droplet formation compared
with the control (Fig. 2c). Lipid droplets formation was detected by
oil red O staining at 6 d after adipogenesis induction. Additionally,
the expression of adipogenic markers, such as PPAR-c (Non-
targeting, 6.30 6 0.54; DJ-1, 2.57 6 0.19 folds), aP2 (Non-
targeting, 3.07 6 0.11; DJ-1, 1.17 6 0.10 folds) and lipoprotein
lipase (LPL) (Non-targeting, 4.78 6 0.21; DJ-1, 4.05 6 0.15 folds),
was down-regulated in response to DJ-1 deficiency (Fig. 2d).
Similarly, the mRNA level of glucose transporter type 4 (GLUT4)
was reduced in DJ-1-deficient 3T3-L1 cells (Non-targeting, 5.30 6
0.26; DJ-1, 4.16 6 0.29 folds). Adipogenic marker expression was
examined by RT-PCR at 6 d after adipogenesis induction. The
down-regulation of adipogenic genes in response to DJ-1 knock-
down was shown prior to and during the early stages of adipocyte
differentiation (Supplementary Fig. S1). Taken together, these results
suggest that the endogenous expression of DJ-1 is required for the
adipogenic program of 3T3-L1 cells from the early to late stages of
differentiation.
DJ-1 deficiency results in reduced expression of pro-inflammatory
cytokines. Next, we tested whether the elevated expression of DJ-1 in
3T3-L1 cells is related to the regulation of inflammatory markers. The
knock-down of DJ-1 using siRNA treatment in 3T3-L1 cells
significantly suppressed the expression level of cytokines, including
interleukin-1b (IL-1b) (Non-targeting, 4.17 6 0.34; DJ-1, 1.81 6 0.09
folds), IL-6 (Non-targeting, 5.80 6 0.22; DJ-1, 2.09 6 0.10 folds) and
monocyte chemotactic protein-1 (MCP-1) (Non-targeting, 2.43 6
0.16; DJ-1, 1.22 6 0.25 folds) under adipogenic differentiation
conditions (Fig. 3a). DJ-1-deficient 3T3-L1 cells showed a reduced
expression of these cytokines prior to adipogenic induction
Figure 2 | DJ-1 deficiency results in impaired adipocyte differentiation. (a) 3T3-L1 cells were transfected with non-targeting or anti-DJ-1 siRNA (10
nM). After the 3T3-L1 cells were grown to confluence, the cells were cultured under adipogenic induction medium (AIM). The knock-down of DJ-1 was
confirmed by immunoblotting at 0 d and 6 d after adipogenesis induction. Quantification of DJ-1/actin protein ratio was shown below each blot. (b) To
determine cell viability, the MTT assay was performed. Non-targeting or anti-DJ-1 siRNA-treated 3T3-L1 cells were grown under adipogenic
differentiation conditions. Cell viability was examined at 0 d and 6 d after adipogenesis induction. NS, not significant. (c) 3T3-L1 cells were transfected
with non-targeting or anti-DJ-1 siRNA, and the cells were grown under adipogenic differentiation conditions for 6 d. The knock-down ofDJ-1 exhibited a
reduced lipid droplet formation, as determined by oil red O staining. Differentiated adipocytes were photographed (x200) at 6 d after adipogenesis
induction. Scale bar5 100 mm. (d) The expression of adipocyte-specific marker genes andGLUT4were lower in anti-DJ-1 siRNA-treated cells at 6 d after
adipogenesis. *, p , 0.05 and **, p , 0.01 versus the control. All data are presented as the mean 6 s.d.
www.nature.com/scientificreports
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(Supplementary Fig. S2). Similarly, the secretion of IL-6 was down-
regulated in anti-DJ-1 siRNA-treated cells during adipogenesis
(Fig. 3b). IL-6 concentration was enhanced as a result of the
adipogenic differentiation of 3T3-L1 cells (8180.84 6 27.93 pg/ml
at 6 d), and DJ-1 deficiency resulted in reduced IL-6 secretion
(3652.54 6 696.15 pg/ml at 6 d). Because IL-1b, IL-6 and MCP-1
are NF-kB target genes20,21 and DJ-1 has been known to enhance NF-
kB translocation and transcriptional activity22, we tested the effect of
DJ-1 knock-down on NF-kB transcriptional activity by examining
reporter-gene activity. Because the transfection efficiency of reporter
plasmid was very low in 3T3-L1 cells, we performed this experiment
in RAW264.7 cells (a mouse macrophage cell line)23. The basal level
Figure 3 | DJ-1 regulates the expression of NF-kB target cytokines. (a) The expression of pro-inflammatory cytokines, including IL-1b, IL-6 andMCP-1
at 6 d after adipogenesis induction in 3T3-L1 cells. *, p, 0.05 and **, p, 0.01 versus the control. (b) The secretion of IL-6 in anti-DJ-1 siRNA-treated
3T3-L1 cells was determined with a multiplex mouse adipokine assay. The IL-6 concentration in 3T3-L1 cells was examined from 0 d to 6 d after
adipogenesis induction. *, p , 0.05 and **, p , 0.01 versus the control. (c) NF-kB activity was examined using the luciferase reporter gene assay in
RAW264.7 cells in the absence or presence of LPS (100 ng/ml). Knock-down cells were incubated with LPS for 8 h, and luciferase activity was determined.
*, p, 0.05 versus the control. #, p, 0.05 versus the vehicle. (d) The concentration of nitrate was detected in non-targeting or anti-DJ-1 siRNA-treated
cells. After RAW264.7 cells were transfected with siRNA, the cells were treated with LPS (100 ng/ml) for 8 h. *, p, 0.05 versus the control. #, p, 0.05
versus the vehicle. All data are presented as the mean 6 s.d.
www.nature.com/scientificreports
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of NF-kB transcriptional activity was reduced in DJ-1-deficient cells
(Non-targeting, 1.0 6 0.0; DJ-1, 0.3 6 0.1 folds). NF-kB luciferase
activity was reduced in DJ-1-deficient cells (5.6 6 0.1 folds)
compared with the control (12.0 6 0.3 folds) in response to
lipopolysaccharides (LPS) treatment (Fig. 3c). Additionally, LPS-
stimulated nitrate production, which is a marker of NF-kB
activation and inflammation24,25, was reduced in DJ-1-deficient
RAW264.7 cells (Non-targeting, 22.9 6 0.3; DJ-1, 8.9 6 0.7 folds)
(Fig. 3d). Similarly, the gene expression levels of IL-1b, IL-6 and
MCP-1 were down-regulated in anti-DJ-1 siRNA-treated
RAW264.7 cells in the presence of LPS (Supplementary Fig. S3).
However, DJ-1 had no effect on the expression of anti-
inflammatory cytokines, including IL-10 and Arginase-1 (data not
shown). Next, to determine whether DJ-1-mediated NF-kB activity is
related to adipogenesis, DJ-1-deficient cells were treated with or
without Bay 11-7082 (an inhibitor of NF-kB) for 6 d under
adipogenic differentiation conditions. The expression levels of
PPAR-c and LPL were increased by Bay 11-7082 in both non-
targeting siRNA and anti-DJ-1 siRNA-treated 3T3-L1 cells,
whereas aP2 expression was not changed (Supplementary Fig. S4),
and Bay 11-7082 did not increase lipid droplet formation suppressed
by DJ-1 knock-down (data not shown). These results suggest that DJ-
1 regulates the expression of pro-inflammatory cytokines, possibly
through the regulation of NF-kB activity, and DJ-1-mediated NF-kB
activity might not be sufficient to regulate adipogenesis.
DJ-1 knock-out mice show increased level of glucose in the HFD-
induced obesity model. To further investigate the role of DJ-1 in
metabolic control, we used the HFD-induced obesity model26,27 in
wild-type (WT) and DJ-1 knock-out mice. WT and DJ-1 knock-out
(DJ-1 KO) mice were fed an HFD for 12 weeks. Although body
weight was increased in both WT and DJ-1 KO mice owing to the
HFD, the change in body weight betweenWT andDJ-1 KOmice was
not significant during 12 weeks after the HFD (Supplementary Fig.
S6a). To further understand the role of DJ-1 in glucose homeostasis
and insulin sensitivity, we performed glucose tolerance tests (GTTs)
and insulin tolerance tests (ITTs) inWT and DJ-1 KOmice that had
been fed an HFD at 6 weeks and 12 weeks (Supplementary Fig. S5,6).
Several reports suggest that DJ-1 has a protective role in pancreatic
beta-cells and DJ-1 KO mice show the reduced insulin secretion
according to the HFD and aging17,28. At 6 weeks, there was no
difference in glucose homeostasis and insulin action between WT
and DJ-1 KO mice (Supplementary Fig. S5a,b). Interestingly, at 12
weeks, DJ-1 KO mice showed glucose intolerance compared with
WT mice in response to glucose injection (Supplementary Fig.
S6b). However, in response to insulin administration, there was no
difference in DJ-1 KO mice and WT (Supplementary Fig. S6c). In
addition, the basal fasting glucose level was increased in DJ-1 KO
mice (143.78 mg/dl) comparedwithWTmice (126.89 mg/dl). These
results support that DJ-1 KOmice might have the problem in insulin
secretion owing to HFD-induced obesity.
DJ-1 deficiency shows reduced inflammation in WAT. Next, we
performed a histological analysis by adopting H&E staining of WAT
in WT and DJ-1 KO mice (Fig. 4a). DJ-1-deficient mice showed no
remarkable difference in adipocyte size and number. However,
mononuclear cells infiltration was increased in WT mice, whereas
DJ-1 KO mice exhibited a decrease of mononuclear cell infiltration
and a mild inflammatory response. Consistent with the histological
analysis, IL-6 expression in the WAT of DJ-1-deficient mice was
reduced compared with the WAT of WT mice (WT, 1.00 6 0.38;
DJ-1KO, 0.216 0.05 folds) (Fig. 4b). Additionally, the secretion level
of IL-6 was decreased in the serum of DJ-1 KO mice compared with
WT mice (WT, 71.60 6 26.37; DJ-1 KO, 16.18 6 4.19 pg/ml)
(Fig. 4c). We also examined the expression of adipogenic marker
genes and other pro-inflammatory genes. The expression of these
genes was also lightly reduced in the WAT of DJ-1 KO mice
(Supplementary Fig. S7). However, it did not show a remarkable
change. Taken together, these results suggest that DJ-1-deficient
mice exhibit a reduced inflammatory response with mild activity in
adipocytes under HFD conditions.
Discussion
In this study, we investigated the role of DJ-1 in metabolic control
using the HFD-induced obesity model. DJ-1 expression was
increased during adipogenesis, and DJ-1 deficiency resulted in
impaired adipogenic differentiation and reduced lipid droplet
formation in 3T3-L1 cells. Additionally, our results show that DJ-1
regulates the expression of pro-inflammatory cytokines by regulating
NF-kB transcriptional activity. Furthermore, DJ-1-deficient mice
showed reduced inflammation in response to HFD. Indeed, IL-6
expression and secretion were down-regulated in DJ-1-deficient
mice. Taken together, these results indicate previously unknown
functions of DJ-1 in adipogenesis and inflammation in metabolic
regulation (Fig. 4d).
To date, the role of DJ-1 in cell differentiation and adipogenesis
has been largely unknown29. Because DJ-1 has important roles in
oxidative stress regulation and cell survival, the role of DJ-1 has been
suggested to be related to insulin secretion. In DJ-1-deficient mice,
the defense mechanism against oxidative stress is absent. Thus, the
dysregulation of the oxidative stress caused by an HFD and aging
leads to the disruption of pancreatic islets, resulting in reduced insu-
lin secretion17,30. In our experiments, DJ-1-deficient mice showed a
significant increase in fasting glucose level at 12 weeks after HFD
(Supplementary Fig. S6b,c). These results suggest that DJ-1 defi-
ciency induces the reduction in insulin secretion as previously
reported17. On the other hand, several previous reports showed that
DJ-1 expression was higher in obesity-resistant rats and suggested a
possible role of DJ-1 in adipogenesis associated with androgen recep-
tor-mediated signaling pathway31–33. It is supposed that androgen
inhibits adipogenesis of mouse pluripotent cells. However, it is
unclear that DJ-1 deficiency causes obesity andDJ-1 regulates andro-
gen receptor in 3T3-L1 cells. The effect of DJ-1 on adipogenesis
might be dependent on differentiation stage and cellular context.
Still, the putative activity of DJ-1 in adipogenesis and metabolic
function has been poorly understood.
Our findings show that DJ-1 mRNA and protein expression was
up-regulated owing to the adipocyte differentiation of 3T3-L1 cells.
However, DJ-1 secretion was not altered during adipogenesis.
Accordingly, endogenous intracellular DJ-1 levels might be required
for adipogenic differentiation. DJ-1 deficiency resulted in reduced
lipid droplet formation and the down-regulation of adipocyte-spe-
cific marker genes in 3T3-L1 cells. Indeed, the mRNA levels of adi-
pogenic genes, including PPAR-c, were reduced in DJ-1-deficient
cells without adipogenic induction (Supplementary Fig. S1), and
these genes were down-regulated up to terminal differentiation
(Fig. 2d). These results show that reduced expression of PPAR-c
due to the loss of DJ-1 might be sufficient to impair adipogenic
differentiation. These results suggest that DJ-1 might control adipo-
genesis through the regulation of adipogenic gene expression.
However, the detailed molecular mechanism underlying DJ-1-
mediated adipogenesis needs further investigation.
Several reports have suggested that DJ-1 has anti-inflammatory
functions in astrocytes and microglia associated with Parkinson’s
disease pathogenesis34,35. To date, there is no direct evidence to
show the role of DJ-1 in pro-inflammatory response. However,
our results show that DJ-1 increases the transcriptional activity of
NF-kB and the expression of its target genes. These results support
that DJ-1 enhances NF-kB nuclear translocation and transcriptional
activity22. The expression of NF-kB target genes, such as IL-1b, IL-6
and MCP-1, was down-regulated in DJ-1-deficient 3T3-L1 cells and
RAW264.7 cells (Fig. 3a, Supplementary Fig. S2,3). Accordingly,
the role of DJ-1 in inflammation might be dependent on cellular
www.nature.com/scientificreports
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type and DJ-1 seems to have different intracellular signaling path-
ways. The investigation of DJ-1-mediated signaling pathways in vari-
ous cellular types would be needed to define the function of DJ-1 in
inflammatory response. On the other hand, the inhibition of NF-kB
activity did not show a significant effect on adipogenesis in DJ-1-
deficient 3T3-L1 cells, although adipogenic marker gene expression
was slightly increased (Supplementary Fig. S4). Numerous reports
have suggested that the NF-kB signaling pathway and PPAR-c
activation have an inverse relationship and that PPAR-c has anti-
inflammatory effects36–39. However, in our results, DJ-1 deficiency
resulted in the down-regulation of both PPAR-c expression and NF-
kB transcriptional activity, suggesting that DJ-1 might control
adipogenesis and inflammation through distinct mechanisms.
DJ-1-mediated NF-kB activity might not be involved in adipogenic
differentiation.
Furthermore, we examined the role of DJ-1 in metabolic control
by using the HFD-induced obesity model. DJ-1-deficient mice fed an
HFD showed a significant reduction in inflammation, whereas there
was no remarkable difference in adipocyte size and number at 12
weeks after HFD (Fig. 4a). Additionally, the expression and secretion
of IL-6 was decreased in DJ-1-deficient mice (Fig. 4b,c). IL-6 is a key
pro-inflammatory cytokine that is closely associated with insulin
resistance in obesity40,41. Accordingly, DJ-1 might function as a
strong regulator in pro-inflammation rather than adipogenesis in
vivo. However, adipose tissue-specific or macrophage-specific DJ-
1-deficient mice might have different phenotypes, and developing
conditional knock-out mice might be a useful tool for defining the
function of DJ-1 clearly in metabolic regulation.
In conclusion, our study identifies previously undefined functions
of DJ-1 in adipogenesis and inflammation in metabolic regulation.
Figure 4 | Inflammation is down-regulated in DJ-1 KOmice. (a) Representative H&E-stained images (x200). The white adipose tissue (WAT) samples
were obtained fromWT and DJ-1 KOmice at 12 week after HFD. Scale bar 5 100 mm. Left, image for WAT of WT; Right, image for WAT of DJ-1 KO.
Black filled arrows indicate the infiltration of mononuclear cell. (b) The expression levels of IL-6 in the WAT from WT and DJ-1 KO mice fed an
HFD for 12 weeks were determined by quantitative RT-PCR. *, p, 0.05 versus the WTmice. n 5 9 per group. (c) The IL-6 concentration in the serum
from WT and DJ-1 KO mice was detected with a multiplex mouse adipokine assay. *, p , 0.05 versus the WT mice. n 5 9 per group. All data are
presented as the mean 6 s.e.m. (d) Proposed mechanism for functions of DJ-1 in metabolic control.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 4805 | DOI: 10.1038/srep04805 6
The loss of DJ-1 resulted in impaired adipogenesis and reduced
inflammation in vitro and a mild inflammatory response in vivo.
Taken together, these results suggest that precise regulation of DJ-
1 in metabolic organ might bring a therapeutic advantage for obesity
and obesity-related metabolic disease treatment.
Methods
Cell culture.Mouse pre-adipocyte 3T3-L1 cells were purchased from ATCC. 3T3-L1
cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) (Lonza,
Walkersville, MD) supplemented with 10% fetal bovine serum (FBS, Gibco BRL,
Grand Island, NY), 100 units/ml penicillin and 100 mg/ml streptomycin (Gibco
BRL). For adipogenesis induction, 3T3-L1 cells were plated at 105 cells/well in a six-
well plate. After the 3T3-L1 cells were grown to confluence, the cells were cultured
under adipogenic inductionmedium (AIM, 10% FBS, 1 mMdexamethasone, 500 mM
3-isobutyl-1-methylxanthine and 1 mM insulin in DMEM). The cells were treated
with AIM every 2 d for 6 or 8 d. To verify the effect of DJ-1 knock-down on
adipogenesis of 3T3-L1 cells, only insulin was included in AIM. All components of
AIM were purchased from Sigma-Aldrich. RAW264.7 cells were maintained in
DMEM supplemented with 10% FBS, 100 units/ml penicillin and 100 mg/ml
streptomycin.
Oil red O staining. To detect lipid droplet formation in differentiated 3T3-L1 cells,
oil red O staining was performed as previously described with some modifications42.
Images were visualized using an Olympus IX 71 microscope equipped with an
Olympus DP72 camera.
Knock-down of DJ-1. Non-targeting siRNA duplexes (59-CGUUAAUCGCGUA-
UAAUACGCGUA-39) and anti-DJ-1 siRNA duplexes (59ACCUUGCUAGUA-
GAAUAAACAGU-39) were purchased from Integrated DNA Technologies
(Coralville, IA). 3T3-L1 cells or RAW264.7 cells were transfected with against non-
targeting and anti-DJ-1 siRNA (10 nM) using Lipofectamin RNAiMAX transfection
reagent (Invitrogen, Carlsbad, CA). Cells were used for the experiment after 48–72 h
of culture.
MTT assay. Cell viability was determined using the MTT assay. Briefly, 3T3-L1 cells
were plated at 8 3 104 cells/well in six-well plates. After the transfection of non-
targeting or DJ-1-targeting siRNA, 3T3-L1 cells were grown to confluence. TheMTT
assay was performed at 0 d and 6 d after adipogenesis induction. The cells were
incubatedwith theMTT solution (0.5 mg/mlMTT in PBS) for 3 h at 37uC. The newly
formed crystals were dissolved in DMSO and absorbance was measured at 540 nm.
cDNA synthesis and quantitative RT-PCR. Total RNAwas extracted from cells and
adipose tissues using TRIzol (Invitrogen, Grand Island, NY). cDNA synthesis and
quantitative RT-PCR were performed as previously reported with some
modifications29. SYBR Green I Master mix (Roche, Indianapolis, IN) and a Roche
LightCycler 480 RT-PCR system were used. The primers used for PCR are described
in Supplementary Table S1. The expression levels of the mRNAs were normalized to
the expression level of 36B4 and then compared.
Detection of IL-6 concentration. IL-6 secretion in cell culture supernatant and
serumwas analyzed by using themultiplexmouse adipokine kit (Millipore) according
to the manufacturer’s instructions.
NF-kB luciferase assay. siRNA-transfected cells were transfected with 0.5 mg of
reporter plasmid (pGL4.32[luc2P/NF-KB-RE/Hygro], Promega) using
Lipofectamine 2000 reagent (Invitrogen). After 24 h, the cells were treated with LPS
(R&D Systems, Minneapolis, MN) for 8 h. The cell lysates were prepared with a
passive lysis buffer and used to measure the luciferase activity according to the
manufacturer’s instructions for the luciferase reporter assay system (Promega). The
luciferase assays were carried out using a GloMax 96 Microplate Luminometer
(Promega). Reporter activity was normalized to the protein content in the cell
extracts. The values shown are averages and standard errors from at least three
independent experiments.
Nitrate assay. The production of nitrite, a stable end product of NO oxidation, was
used as a measure of iNOS activity. The nitrite present in the conditioned media was
determined by a method based on the Griess reaction43. An aliquot of each
supernatant (50 ml) wasmixed with the same volume of Griess reagent (0.1% (w/v)N-
(1-naphathyl)-ethylenediamine and 1% (w/v) sulfanilamide in 5% (v/v) phosphoric
acid) for 10 min at room temperature. The absorbance of the final product was
measured at 520 nm, and the nitrite concentration in the samples was determined
from a standard curve of sodium nitrite prepared in culture medium.
DJ-1 knock-out mice and high-fat diet condition. DJ-1 knock-out mice were
obtained fromDr. Charles R. Gerfen44. Themice were fed a high-fat diet (60% kcal fat,
D12492, Research Diets Inc.) for 12 weeks. The serum samples were obtained by tail
vein bleeds at the indicated intervals. All animal experiments were performed
according to procedures approved by the Ulsan National Institute of Science and
Technology’s Institutional Animal Care and Use Committee.
H&E staining for adipose tissue. Epididymal white adipose tissue was collected
under deep anesthesia after a 16 h fast. The tissue was fixed in 4% paraformaldehyde
and embedded in Tissue Path. Tissue sections (4 mm) were prepared, stained in
hematoxylin and eosin (H&E) and examined under a microscope.
Immunoblotting. Immunoblotting was performed as previously described29. Signals
were visualized by chemiluminescence (ECL system, Amersham Biosciences,
Piscataway, NJ) and detected with an LAS4000 biomolecular imager (GE healthcare).
The primary antibody against DJ-1 was obtained from Abcam (UK), and other
primary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). The horseradish peroxidase-conjugated secondary antibodies were purchased
from KPL (Gaithersburg, MA). The blots were quantified using NIH ImageJ software
and normalized to actin.
Statistical analysis. The data were analyzed using Student’s t- test; p , 0.05 and
p , 0.01 were considered to be significant.
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